A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the ...

Life sciences company Bio-Techne (NASDAQ:TECH) announced better-than-expected revenue in Q2 CY2025, with sales up 3.5% year ...

明尼阿波利斯 - Bio-Techne Corporation (NASDAQ: TECH )周三宣布，其董事会已批准截至2025年6月30日季度的每股0.08美元的季度股息。根据 InvestingPro 数据，该公司已连续18年保持股息支付，目前年股息收益率为0.59%。

Bio-Techne Corporation (纳斯达克股票代码:TECH)是一家全球生命科学公司，为研究和临床诊断领域提供创新工具和生物活性试剂。 Bio-Techne产品有助于对生物过程和特定疾病的性质和进展进行科学研究。 它们有助于药物发现，并提供准确的临床测试和诊断手段。

Bio-Techne on Wednesday said it expects uncertainty related to U.S. President Donald Trump's tariff and academic funding policies to spill into its fiscal year 2026 and could create pressure on the ...